Bottom line
Is DOCT a good fund? The bottom line
DOCT is an actively managed buffer / defined outcome ETF from First Trust.
It charges 0.85% — about $85 a year on every $10,000 invested, more expensive than 81% of buffer / defined outcome funds we track.
It returned +8.1% over one year (as of Dec 31, 2024, per its prospectus).
With $389 million in net assets and 17 holdings, its largest position is Cboe Global Markets, Inc. (95.6%) and the top 10 make up 106.3% of the portfolio.
What to watch
- Expensive for its category (0.85%)
- Concentrated: top 10 holdings are 106.3% of assets
Updated Nov 19, 2026
What DOCT invests in
The investment objective of the FT Vest U.S. Equity Deep Buffer ETF October (the Fund ) is to seek to provide investors with returns (before fees and expenses) that match the price return of the State Street SPDR S&P 500 ETF Trust (the Underlying ETF ), up to a predetermined upside cap of 14.18% while providing a buffer (before fees and expenses) against Underlying ETF losses between -5% and -30%, over the period from October 19, 2026 through October 15, 2027.
"Under normal market conditions, the Fund will invest substantially all of its assets in FLexible EXchange Options ( FLEX Options ) that reference the price performance of the State Street SPDR S&P 500 ETF Trust (the Underlying ETF"" ). FLEX Options are customized equity or index option contracts that trade on an exchange, but provide investors with the ability to customize key contract terms like exercise prices, styles and expiration dates. The Underlying ETF is an exchange-traded unit investment trust that uses a replication strategy, meaning it invests in as many of the stocks in the S&P 500 Index as is practicable. PDR Services, LLC ( PDR ) serves as the Underlying ETFs sponsor. The investment objective of the Underlying ETF is to seek to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index. The Fund's…
From the fund's prospectus (filed Oct 19, 2026).
DOCT performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DOCT | +8.1% | — | — |
| Buffer / Defined Outcome median | +10.6% | +2.2% | +2.9% |
Source: Fund prospectus, as of Dec 31, 2024
What DOCT costs
On a $10,000 investment, DOCT's 0.85% expense ratio costs about $85 a year. The median buffer / defined outcome fund charges 0.74%.
DOCT top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Cboe Global Markets, Inc. | 95.61% |
| 2 | Cboe Global Markets, Inc. | 7.44% |
| 3 | Cboe Global Markets, Inc. | 1.23% |
| 4 | Cboe Global Markets, Inc. | 0.71% |
| 5 | Cboe Global Markets, Inc. | 0.61% |
| 6 | Dreyfus Government Cash Management Funds | 0.61% |
| 7 | Cboe Global Markets, Inc. | 0.04% |
| 8 | Cboe Global Markets, Inc. | 0.01% |
| 9 | Cboe Global Markets, Inc. | 0.00% |
| 10 | Cboe Global Markets, Inc. | 0.00% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 106.3% of the fund. See all top 25 holdings and asset mix →